Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægerne Græsted Tandklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.9% 8.6% 3.4% 2.5% 2.1% 2.2% 6.3% 6.3%   Credit score (0-100)   60 30 54 61 66 64 38 38   Credit rating   BBB BB BBB BBB A BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,050 711 857 3,466 3,116 3,210 0.0 0.0   EBITDA   150 -84.2 222 1,116 684 635 0.0 0.0   EBIT   103 -111 122 742 294 224 0.0 0.0   Pre-tax profit (PTP)   86.2 -126.3 92.9 636.0 191.9 110.6 0.0 0.0   Net earnings   67.3 -98.5 64.5 477.1 149.7 86.6 0.0 0.0   Pre-tax profit without non-rec. items   86.2 -126 92.9 636 192 111 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   80.2 53.7 666 606 552 514 0.0 0.0   Shareholders equity total   459 307 316 737 829 857 671 671   Interest-bearing liabilities   0.0 0.0 2,509 2,321 1,927 1,749 848 848   Balance sheet total (assets)   817 621 3,215 3,607 3,162 3,064 1,519 1,519   Net Debt   -635 -454 2,302 1,484 1,737 1,386 848 848     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,050 711 857 3,466 3,116 3,210 0.0 0.0   Gross profit growth   -14.3% -32.3% 20.6% 304.5% -10.1% 3.0% -100.0% 0.0%   Employees   3 3 3 4 5 6 0 0   Employee growth %   0.0% 0.0% 0.0% 33.3% 25.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   817 621 3,215 3,607 3,162 3,064 1,519 1,519   Balance sheet change%   -3.7% -24.0% 417.9% 12.2% -12.3% -3.1% -50.4% 0.0%   Added value   149.6 -84.2 222.1 1,116.3 668.0 634.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -78 -53 2,705 -659 -669 -674 -514 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.8% -15.6% 14.2% 21.4% 9.4% 7.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.4% -15.3% 6.4% 21.8% 8.7% 8.1% 0.0% 0.0%   ROI %   22.8% -28.7% 7.8% 24.7% 9.7% 8.9% 0.0% 0.0%   ROE %   14.9% -25.7% 20.7% 90.7% 19.1% 10.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   56.2% 49.4% 9.8% 20.4% 26.2% 28.0% 44.2% 44.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -424.5% 539.0% 1,036.4% 133.0% 254.0% 218.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 794.1% 315.1% 232.4% 204.2% 126.4% 126.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 2.3% 4.4% 4.8% 7.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 1.6 0.5 1.1 1.7 1.8 0.0 0.0   Current Ratio   2.2 1.8 0.5 1.2 1.8 1.9 0.0 0.0   Cash and cash equivalent   635.1 454.0 207.4 837.0 189.9 363.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   386.6 235.9 -281.1 147.5 376.9 493.8 -424.0 -424.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   50 -28 74 279 134 106 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   50 -28 74 279 137 106 0 0   EBIT / employee   34 -37 41 185 59 37 0 0   Net earnings / employee   22 -33 21 119 30 14 0 0